ETST logo

Earth Science Tech, Inc. (ETST) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

ETST, $ (piyasa değeri 0) fiyatla Healthcare işi olan Earth Science Tech, Inc.'i temsil ediyor. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 61/100 puan alıyor.

Son analiz: 17 Mar 2026
61/100 AI Puanı

Earth Science Tech, Inc. (ETST) Sağlık ve Boru Hattı Genel Bakışı

CEOGiorgio R. Saumat
Çalışanlar32
MerkezMiami, US
Halka Arz Yılı2014
SektörHealthcare

Earth Science Tech, Inc. operates in the healthcare sector, focusing on nutraceuticals and dietary supplements for various health conditions. With a market capitalization of $0.03 billion and a P/E ratio of 9.88, the company distributes its products through retail, clinics, pharmacies, and online channels, competing in a fragmented market.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 17 Mar 2026

Yatırım Tezi

Earth Science Tech, Inc. presents a speculative investment opportunity within the nutraceutical and dietary supplement market. With a market capitalization of $0.03 billion and a P/E ratio of 9.88, the company's valuation reflects both its growth potential and inherent risks associated with OTC-listed companies. A gross margin of 65.1% indicates strong pricing power, while a profit margin of 10.0% demonstrates profitability. Growth catalysts include expanding its online presence and developing new formulations for existing products. However, potential risks include the company's reliance on a limited product line and the competitive nature of the nutraceutical market. The company's high beta of 2.02 suggests significant volatility, making it suitable for investors with a high-risk tolerance. The lack of dividend yield further emphasizes its growth-oriented profile.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market capitalization of $0.03 billion indicates a small-cap company with potential for growth but also higher risk.
  • P/E ratio of 9.88 suggests the company is potentially undervalued compared to its earnings.
  • Gross margin of 65.1% reflects strong pricing power and efficient cost management.
  • Profit margin of 10.0% demonstrates the company's ability to generate profit after all expenses.
  • Beta of 2.02 indicates high volatility compared to the market, suggesting higher risk and potential reward.

Rakipler & Benzerleri

Güçlü Yönler

  • Diverse product line targeting various health conditions.
  • Multi-channel distribution network.
  • Strong gross margin indicating pricing power.
  • Focus on natural and alternative health solutions.

Zayıflıklar

  • Small market capitalization and limited financial resources.
  • High beta indicating significant volatility.
  • Reliance on a limited number of key products.
  • Limited brand recognition compared to larger competitors.

Katalizörler

  • Upcoming: Potential new product launches in the nutraceutical and dietary supplement market.
  • Ongoing: Expansion of online presence and e-commerce sales channels.
  • Ongoing: Strategic partnerships with clinics, pharmacies, and healthcare providers.

Riskler

  • Potential: Intense competition from larger and more established companies in the nutraceutical industry.
  • Potential: Changing regulations and compliance requirements affecting the dietary supplement market.
  • Potential: Fluctuations in raw material prices impacting the company's profitability.
  • Ongoing: Limited financial resources and small market capitalization.
  • Ongoing: High beta indicating significant price volatility.

Büyüme Fırsatları

  • Expanding Online Presence: ETST can capitalize on the growing e-commerce trend by enhancing its online platform and digital marketing efforts. The global e-commerce market is projected to reach trillions of dollars in the coming years, offering a significant opportunity for ETST to increase its sales and market reach. By investing in SEO, social media marketing, and targeted advertising, ETST can attract new customers and drive online sales, with an expected impact within the next 1-2 years.
  • Developing New Formulations: ETST can invest in research and development to create new and innovative formulations for its existing products. The nutraceutical industry is constantly evolving, with new ingredients and delivery methods emerging regularly. By staying ahead of the curve and developing unique and effective formulations, ETST can differentiate itself from competitors and attract health-conscious consumers. This could lead to new product launches within the next 18-24 months.
  • Strategic Partnerships: ETST can form strategic partnerships with clinics, pharmacies, and healthcare providers to expand its distribution network and reach a wider audience. Collaborating with established healthcare professionals can enhance ETST's credibility and build trust with consumers. These partnerships could be established within the next year, leading to increased sales and market penetration.
  • Geographic Expansion: ETST can explore opportunities to expand its operations into new geographic markets, particularly in regions with a growing demand for nutraceuticals and dietary supplements. Emerging markets in Asia and Latin America offer significant growth potential. By conducting market research and adapting its products to local preferences, ETST can successfully enter new markets and diversify its revenue streams over the next 2-3 years.
  • Focus on Specific Health Conditions: ETST can focus its marketing efforts on specific health conditions, such as chronic pain, joint pain, and inflammation. By targeting consumers with specific health needs, ETST can increase its brand awareness and build a loyal customer base. This targeted approach can be implemented within the next 6-12 months, leading to improved marketing ROI and increased sales.

Fırsatlar

  • Expanding online presence and e-commerce sales.
  • Developing new and innovative product formulations.
  • Forming strategic partnerships with healthcare providers.
  • Entering new geographic markets with growing demand for nutraceuticals.

Tehditler

  • Intense competition from larger and more established companies.
  • Changing regulations and compliance requirements.
  • Fluctuations in raw material prices.
  • Negative publicity or adverse events affecting the nutraceutical industry.

Rekabet Avantajları

  • Proprietary formulations and unique product offerings.
  • Established distribution network through multiple channels.
  • Brand recognition and customer loyalty in specific market segments.

ETST Hakkında

Earth Science Tech, Inc. (ETST) is a biotechnology company that develops, markets, and distributes nutraceuticals, bioceuticals, and dietary supplements. Founded in 2010 and formerly known as Ultimate Novelty Sports, Inc., the company rebranded in March 2014 to focus on health and wellness products. Headquartered in Doral, Florida, ETST offers a range of products targeting chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. The company's product portfolio includes hemp oils, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. These are available in various formulations such as capsules, tablets, soft gels, chewables, liquids, creams, sprays, and powders. ETST distributes its products through multiple channels, including its retail store, clinics, pharmacies, and online platforms. This multi-channel approach aims to maximize market reach and cater to diverse customer preferences. ETST also provides medical equipment and devices, further diversifying its offerings within the healthcare sector. The company operates with 32 employees and aims to expand its market presence through innovative product development and strategic distribution partnerships.

Ne Yaparlar

  • Develops and markets nutraceuticals and bioceuticals.
  • Offers dietary supplements for various health conditions.
  • Provides products targeting chronic pain, joint pain, and inflammation.
  • Distributes hemp oils, vitamins, minerals, and herbs.
  • Sells personal care products, homeopathies, and functional foods.
  • Offers medical equipment and devices.

İş Modeli

  • Develops and manufactures nutraceutical and dietary supplement products.
  • Distributes products through retail stores, clinics, pharmacies, and online channels.
  • Generates revenue through the sale of its products to consumers and healthcare providers.

Sektör Bağlamı

Earth Science Tech, Inc. operates within the growing nutraceutical and dietary supplement industry. This market is characterized by increasing consumer awareness of health and wellness, driving demand for natural and alternative health solutions. The industry is highly competitive, with numerous players ranging from large pharmaceutical companies to smaller, specialized firms. ETST competes with companies offering similar products, focusing on specific health conditions and distribution channels. The global nutraceutical market is expected to continue growing, driven by aging populations and rising healthcare costs.

Kilit Müşteriler

  • Individuals seeking natural health and wellness solutions.
  • Patients with chronic pain, joint pain, and inflammation.
  • Healthcare providers recommending supplements to their patients.
  • Consumers interested in vitamins, minerals, and herbal remedies.
AI Güveni: 69% Güncellendi: 17 Mar 2026

Finansallar

Grafik & Bilgi

Earth Science Tech, Inc. (ETST) hisse senedi fiyatı: Price data unavailable

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

ETST için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

ETST için Wall Street fiyat hedefi analizi.

MoonshotScore

61/100

Bu puan ne anlama geliyor?

MoonshotScore, ETST'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Giorgio R. Saumat

CEO

Giorgio R. Saumat serves as the Chief Executive Officer of Earth Science Tech, Inc. His background includes experience in managing and growing businesses, with a focus on strategic planning and operational efficiency. He is responsible for overseeing the company's overall strategy, product development, and market expansion efforts. His leadership aims to drive innovation and growth within the nutraceutical and dietary supplement market.

Sicil: Under Giorgio R. Saumat's leadership, Earth Science Tech, Inc. has focused on expanding its product line and distribution channels. Key achievements include the development of new formulations and the establishment of strategic partnerships. His tenure has been marked by efforts to increase brand awareness and market penetration within the competitive nutraceutical industry.

ETST OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Earth Science Tech, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: As an OTC-listed stock, ETST likely experiences lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at desired prices. The limited liquidity may also contribute to increased price volatility and potential for manipulation.
OTC Risk Faktörleri:
  • Limited financial disclosure and transparency.
  • Lower trading volumes and liquidity.
  • Greater price volatility and potential for manipulation.
  • Higher risk of fraud or mismanagement.
  • Limited regulatory oversight and investor protection.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's OTC Markets profile and disclosure history.
  • Check for any regulatory actions or legal proceedings involving the company.
  • Consult with a qualified financial advisor before investing.
  • Understand the risks associated with investing in OTC stocks.
Meşruiyet Sinyalleri:
  • Company has been in operation since 2010.
  • Company has a diverse product line targeting various health conditions.
  • Company distributes products through multiple channels, including retail stores and online platforms.

ETST Hakkında Sıkça Sorulan Sorular

ETST için değerlendirilmesi gereken temel faktörler nelerdir?

Earth Science Tech, Inc. (ETST) şu anda yapay zeka skoru 61/100, orta puanı gösteriyor. Temel güçlü yan: Diverse product line targeting various health conditions.. İzlenmesi gereken birincil risk: Potential: Intense competition from larger and more established companies in the nutraceutical industry.. Bu bir finansal tavsiye değildir.

ETST MoonshotScore'u nedir?

ETST şu anda MoonshotScore'da 61/100 (Derece B) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

ETST verileri ne sıklıkla güncellenir?

ETST fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler ETST hakkında ne diyor?

ETST için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

ETST'a yatırım yapmanın riskleri nelerdir?

ETST için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Intense competition from larger and more established companies in the nutraceutical industry.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

ETST'ın P/E oranı nedir?

ETST için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için ETST'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

ETST aşırı değerli mi, yoksa düşük değerli mi?

Earth Science Tech, Inc. (ETST)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

ETST'ın temettü verimi nedir?

Earth Science Tech, Inc. (ETST) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Information is based on available data and may be subject to change.
  • OTC market data may be less reliable than data from major exchanges.
Veri Kaynakları

Popüler Hisseler